PET/CT with 89Zr-trastuzumab and 18F-FDG to individualize treatment with trastuzumab emtansine (T-DM1) in metastatic HER2-positive breast cancer (mBC).

Gebhart, G; Lamberts, Le; Garcia, C; Ameye, L; Stroobants, S; Huizing, M; Aftimos, Pg; Tol, J; Oyen, W; Wana, Z; van Dongen GAMS,; Hoekstra, Os; Schroder, Cp; Gaye, J; Menke, Cw; Guiot, T; Brouwers, Ah; Awada, A; de Vries EGE,; Flamen, P

doi:10.1200/jco.2014.32.15_suppl.11001

PET/CT with 89Zr-trastuzumab and 18F-FDG to individualize treatment with trastuzumab emtansine (T-DM1) in metastatic HER2-positive breast cancer (mBC) / Gebhart, G; Lamberts, Le; Garcia, C; Ameye, L; Stroobants, S; Huizing, M; Aftimos, Pg; Tol, J; Oyen, W; Wana, Z; van Dongen, Gams; Hoekstra, Os; Schroder, Cp; Gaye, J; Menke, Cw; Guiot, T; Brouwers, Ah; Awada, A; de Vries, Ege; Flamen, P. - In: JOURNAL OF CLINICAL ONCOLOGY. - ISSN 0732-183X. - 32:15(2014).

Titolo:	PET/CT with 89Zr-trastuzumab and 18F-FDG to individualize treatment with trastuzumab emtansine (T-DM1) in metastatic HER2-positive breast cancer (mBC).
Autori:	Gebhart G Lamberts LE Garcia C Ameye L Stroobants S Huizing M Aftimos PG Tol J OYEN, Willem Jozef Gerard Wana Z van Dongen GAMS Hoekstra OS Schroder CP Gaye J Menke CW Guiot T Brouwers AH Awada A de Vries EGE Flamen P mostra contributor esterni nascondi contributor esterni
Data di pubblicazione:	2014
Rivista:	JOURNAL OF CLINICAL ONCOLOGY
Handle:	http://hdl.handle.net/11699/8073
Appare nelle tipologie:	1.5 Abstract in rivista

File in questo prodotto:

Non ci sono file associati a questo prodotto.

Utilizza questo identificativo per citare o creare un link a questo documento:
http://hdl.handle.net/11699/8073

Citazioni

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

CINECA IRIS Institutional Research Information System

File in questo prodotto: